XML 14 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income (loss) $ 5,611 $ (10,504)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation 3,799 3,941
Amortization of intangible assets 1,111 1,136
Reduction in carrying amount of right-of-use asset 2,544 2,449
Provision for credit losses 218 14
Share-based compensation 21,780 19,767
Deferred income taxes 97 39
Provision for (benefit from) excess and obsolete inventory 8 (624)
Non-cash interest expense 306 282
Other (76) 746
Changes in operating assets and liabilities:    
Accounts receivable, net (19,311) (7,709)
Inventories 8,116 (8,669)
Prepaid expenses and other assets (14,016) 3,096
Accounts payable 13,760 14,492
Accrued compensation and benefits (10,726) 2,844
Operating lease liabilities (2,929) (2,757)
Deferred revenue 16,027 3,823
Other current and long-term liabilities (40,317) (3,781)
Net cash provided by (used in) operating activities (13,998) 18,585
Cash flows from investing activities:    
Capital expenditures for property, equipment and capitalized software development costs (6,855) (6,916)
Net cash used in investing activities (6,855) (6,916)
Cash flows from financing activities:    
Borrowings under revolving facility 25,000  
Payments on debt obligations (3,750) (2,500)
Payments on debt financing costs   (695)
Repurchase of common stock (12,000)  
Payments for tax withholdings, net of proceeds from issuance of common stock (10,966) (5,926)
Net cash used in financing activities (1,716) (9,121)
Foreign currency effect on cash and cash equivalents (173) 299
Net increase (decrease) in cash and cash equivalents (22,742) 2,847
Cash and cash equivalents at beginning of period 231,745 156,699
Cash and cash equivalents at end of period $ 209,003 $ 159,546